Nishanth Thavisi

Background

About Nishanth Thavisi

I hold a Master’s degree in Pharmacy (Pharmaceutics) and have built a solid academic and professional foundation in pharmaceutical quality systems within large, regulated healthcare environments. My professional interests center on enterprise quality governance, regulatory compliance strategy, and patient safety. I bring a structured, data-driven approach to quality, strengthened through Six Sigma Black Belt training, and completed an Executive Diploma in Pharmaceutical Regulatory Affairs to further align my expertise with global regulatory expectations. This combination allows me to balance scientific rigor with practical business decision-making.I have 16 years of progressive experience in the pharmaceutical and healthcare manufacturing sector, with hands-on leadership across Sterile Injectables and Oral Solid Dosage operations. I currently serve as Manager – Quality Assurance at Gland Pharma Limited, a globally regulated injectable manufacturer supplying major international markets. My responsibilities span market complaints, APQR/PQR, Continued Process Verification, CAPA, recalls, deviations, change control, validation support, and audit readiness within a corporate quality framework. Earlier roles at Natco Pharma Limited and MSN Laboratories provided strong exposure to IPQA, Quality Management Systems, aseptic manufacturing, and compliance-driven operations. I have consistently supported and contributed to successful inspections by USFDA, MHRA, ANVISA, MFDS, WHO, and multiple global customers.At this stage of my career, I am focused on transitioning into Senior Manager or GM-level leadership roles within corporate pharmaceutical and healthcare organizations, particularly in External Manufacturing, CDMO oversight, and enterprise quality functions. My objective is to lead end-to-end quality governance, strengthen corporate compliance models, and support scalable, inspection-ready operations across internal and external manufacturing networks. I aim to add strategic value by integrating regulatory expectations, quality excellence, and business sustainability, while reinforcing patient safety and long-term organizational credibility.